| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/30/2009 | WO2009054789A1 1,2,3-triazole pyrrolidine derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054786A1 1,2,4-triazole aryl n-oxides derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054785A1 1,2,4-triazole ether derivatives as modulators of mglur5 |
| 04/30/2009 | WO2009054253A1 Organic electroluminescent device, display device and illuminating device |
| 04/30/2009 | WO2009053763A1 New non-peptide derivatives as bradykinin b1 antagonists |
| 04/30/2009 | WO2009053694A1 Therapeutic oxy-phenyl-aryl compounds and their use |
| 04/30/2009 | WO2009053459A1 4-benz0yl-1-substituted-piperazin-2-0ne derivatives as p2x7 modulators |
| 04/30/2009 | WO2009053440A1 Indoline compounds |
| 04/30/2009 | WO2009053373A1 Quinolinone derivatives as parp inhibitors |
| 04/30/2009 | WO2009053269A1 Novel kinase inhibitors |
| 04/30/2009 | WO2009053102A1 Novel imidazole derivatives |
| 04/30/2009 | WO2009053101A1 Novel imidazole derivatives |
| 04/30/2009 | WO2009052708A1 1-(3-amino-propyl)-piperidin-4-yl-amides, pharmaceutical compositions, processes for their preparation and uses |
| 04/30/2009 | WO2009025839A3 Phosphodiesterase 10 inhibitors |
| 04/30/2009 | WO2009021943A3 Novel preparation process |
| 04/30/2009 | WO2009015037A3 5-pyridinone substituted indazoles |
| 04/30/2009 | WO2009010429A3 Novel heterocyclyl compounds and their use as chemokine antagonists |
| 04/30/2009 | WO2008141119A3 Modulators of cftr |
| 04/30/2009 | WO2008140553A4 Mapk/erk kinase inhibitors |
| 04/30/2009 | WO2008115890A3 Mapk/erk kinase inhibitors |
| 04/30/2009 | WO2007086077A3 A novel one pot process for preparation of pantoprazole sodium sesquihydrate |
| 04/30/2009 | US20090111991 Coupling Process For Preparing Quinolone Intermediates |
| 04/30/2009 | US20090111987 reacting a 11H-indeno[1,2-c]quinolin-11-one derivative with hydroxylamine, then alkylation with an alkyl halide to yield )-11H-indeno[1,2-c]quinolin-11-one oxime derivatives, such as 6-hydroxy-9-methoxy-11H-indeno[1,2-c]quinolin-11-one oxime, used in the treatment of cancers and tumors |
| 04/30/2009 | US20090111982 Macrocyclic compounds as inhibitors of viral replication |
| 04/30/2009 | US20090111957 Fluoro-ponytailed bipyridine derivatives and their use as ligands in the metal-catalyzed atrp |
| 04/30/2009 | US20090111857 1,2,4-triazole ether derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111854 1,2,4-triazole aryl n-oxides derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111852 Carboxamide Compound and Use of the Same |
| 04/30/2009 | US20090111851 Antimicrobial Quinolones, Their Compositions and Uses |
| 04/30/2009 | US20090111840 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 04/30/2009 | US20090111838 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors |
| 04/30/2009 | US20090111832 Imidazolidinone Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease |
| 04/30/2009 | US20090111830 7-Chloro-2-[(4,4-difluorocyclohexyl)methyl]-1-oxoisoindoline-5-carbonitrile, used for the treatment of schizophrenia |
| 04/30/2009 | US20090111829 Aripiprazole Salts |
| 04/30/2009 | US20090111828 L-alanine derivatives |
| 04/30/2009 | US20090111825 Thiophene 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111823 Aminopyridine derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111822 1,2,3-triazole pyrrolidine derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111821 Amino 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111819 New pyridazin-3(2h)-one derivatives |
| 04/30/2009 | US20090111815 Carboxamide Compound and Use of the Same |
| 04/30/2009 | US20090111810 Substituted pyrimidine-5-carboxamide and 5-carboxylic ester kinase inhibitors |
| 04/30/2009 | US20090111809 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 04/30/2009 | US20090111808 Novel histamine h3-receptor ligands and their therapeutic applications |
| 04/30/2009 | US20090111804 ARYLINDENOPYRIMIDINES AND THEIR USE AS ADENOSINE A2a |
| 04/30/2009 | US20090111803 novel hydantoin derivatives to inhibit matrix metalloproteinases (MMPs), a disintegrin and metalloproteases (ADAMs) and/or tumor necrosis factor alpha converting enzyme (TACE) and in so doing prevent the release of tumor necrosis factor alpha (TNF- alpha ); autoimmune diseases; side effect reduction |
| 04/30/2009 | US20090111801 Substituted pyrazinone derivatives for use as a medicine |
| 04/30/2009 | US20090111797 (R)-1-(3,4-dibromo-benzyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate, for example; treatment of headaches, particularly migraine or cluster headaches |
| 04/30/2009 | US20090111796 7-membered ring compound and method of production and pharmaceutical application thereof |
| 04/30/2009 | US20090111795 Multimers of Heterocyclic Compounds and Their Use |
| 04/30/2009 | US20090111794 Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase |
| 04/30/2009 | US20090111793 Hydroxyalkanoylaminolactams and related structures as inhibitors of a beta protein production |
| 04/30/2009 | US20090111790 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 04/30/2009 | US20090111789 Chiral cis-imidazolines |
| 04/30/2009 | US20090111731 Novel topical application agents against mimic and age-related wrinkles |
| 04/30/2009 | US20090111692 3-(Pyridin-2-Yl)-[1,2,4]-Triazines as Fungicides |
| 04/30/2009 | CA2703453A1 Indoline compounds |
| 04/30/2009 | CA2703290A1 New non-peptide derivatives as bradykinin b1 antagonists |
| 04/30/2009 | CA2703203A1 Bicyclic heterocycle derivatives and methods of use thereof |
| 04/30/2009 | CA2702786A1 Novel imidazole derivatives |
| 04/30/2009 | CA2702772A1 Diazepane compounds which modulate the cb2 receptor |
| 04/30/2009 | CA2702126A1 Heterocycle amide t-type calcium channel antagonists |
| 04/30/2009 | CA2701747A1 Novel imidazole derivatives |
| 04/30/2009 | CA2701594A1 Heterocycle phenyl amide t-type calcium channel antagonists |
| 04/30/2009 | CA2701275A1 Novel kinase inhibitors |
| 04/30/2009 | CA2699933A1 Fungicidal mixtures |
| 04/29/2009 | EP2053049A1 Preparation of 2' , 6' -di-pyrazolyl-pyridine containing a reactive group R in 4' position |
| 04/29/2009 | EP2053048A1 Chemical in situ sulphonating process |
| 04/29/2009 | EP2053042A1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 04/29/2009 | EP2053041A2 1,3,5-Trisubstituted 2(1H)-pyridones as AMPA receptor inhibitors useful for the treatment of eg Parkinson's disease |
| 04/29/2009 | EP2051978A2 Acetamide derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 04/29/2009 | EP2051975A2 Substituted prolinamides, production thereof and their use as drugs |
| 04/29/2009 | EP2051707A2 Inhibitors of plasma kallikrein |
| 04/29/2009 | EP1828127A4 INSECTICIDAL BIS(SUBSTITUTED PHENYL)-1-äÝ4-(SATURATED HETEROCYCLYL-SUBSTITUTED)PHENYLMETHYL¨-(4-PIPERIDYL)üMETHANE DERIVATIVES |
| 04/29/2009 | EP1786475B1 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri) |
| 04/29/2009 | EP1771421B1 N-hydroxyamide derivatives and use thereof |
| 04/29/2009 | EP1765812B1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
| 04/29/2009 | EP1765775B1 Indoles useful in the treatment of inflammation |
| 04/29/2009 | EP1720844B1 Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases |
| 04/29/2009 | EP1660482B1 3-[(2-{ 4-(hexyloxycarbonylamino-imino-methyl)-phenylamino] -methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino -propionic acid ethyl ester methane sulphonate and use thereof as a medicament |
| 04/29/2009 | EP1446379B1 Aryl aniline beta-2 adrenergic receptor agonists |
| 04/29/2009 | CN101421264A Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| 04/29/2009 | CN101421263A Novel crystalline compounds |
| 04/29/2009 | CN101421262A Compounds and compositions as protein kinase inhibitors |
| 04/29/2009 | CN101421258A Sulfonyl-substituted bicyclic compounds as modulators of ppar |
| 04/29/2009 | CN101421253A Quinazolin-4-one derivatives, process for their preparation and pharmaceutical compositions containing them |
| 04/29/2009 | CN101421250A 4-aryl-2-amino-pyrimidines or 4-aryl-2-aminoalkyl-pyrimidines as jak-2 modulators and pharmaceutical compositions containing them |
| 04/29/2009 | CN101421240A Aminomethyl pyridine derivatives, method for preparing same and therapeutic use thereof |
| 04/29/2009 | CN101421237A Metabotropic glutamate receptor-potentiating soindolones |
| 04/29/2009 | CN101421235A 5-amido-2-carboxamide indoles |
| 04/29/2009 | CN101421234A Heterocyclic arylsulphones suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| 04/29/2009 | CN101420955A Dihydrodiazepines useful as inhibitors of protein kinases |
| 04/29/2009 | CN101417997A Inhibitor compounds containing benzo2-aminoimidazloe skeleton and preparation method thereof |
| 04/29/2009 | CN101417996A Compounds with symmetric structure containing carbazole and naphthalimide groups, preparation method and use thereof |
| 04/29/2009 | CN101417995A Phenoxy pyrimidine derivates and preparation method and use thereof |
| 04/29/2009 | CN101417910A Green nitration method of prazoles intermediate |
| 04/29/2009 | CN100482659C Benzimidazolone compounds having 5-HT4 receptor agonistic activity |
| 04/29/2009 | CN100482658C Process for preparing optically pure active compounds |
| 04/29/2009 | CN100482647C Pyrazole derivatives useful as COX-I inhibitors |
| 04/29/2009 | CN100482229C Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |